D A Loegering

4.0k total citations
36 papers, 3.4k citations indexed

About

D A Loegering is a scholar working on Rheumatology, Physiology and Molecular Biology. According to data from OpenAlex, D A Loegering has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 13 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in D A Loegering's work include Eosinophilic Disorders and Syndromes (13 papers), Asthma and respiratory diseases (10 papers) and Peptidase Inhibition and Analysis (5 papers). D A Loegering is often cited by papers focused on Eosinophilic Disorders and Syndromes (13 papers), Asthma and respiratory diseases (10 papers) and Peptidase Inhibition and Analysis (5 papers). D A Loegering collaborates with scholars based in United States, Sweden and Denmark. D A Loegering's co-authors include Gerald J. Gleich, Evangelo Frigas, D J McKean, James L. Checkel, Steven J. Ackerman, Graham O. Solley, K J Hamann, G.J. Gleich, M P Bell and Nancy R. Slifman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

D A Loegering

36 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D A Loegering United States 24 1.4k 1.2k 939 684 679 36 3.4k
David A. Loegering United States 33 1.4k 1.0× 1.1k 0.9× 974 1.0× 699 1.0× 1.2k 1.8× 55 4.0k
Garry M. Walsh United Kingdom 39 2.9k 2.0× 913 0.8× 1.9k 2.0× 658 1.0× 497 0.7× 142 4.8k
Nives Zimmermann United States 35 2.2k 1.6× 699 0.6× 2.2k 2.3× 969 1.4× 829 1.2× 80 4.5k
Hisao Tomioka Japan 34 1.3k 0.9× 777 0.7× 1.8k 1.9× 474 0.7× 634 0.9× 140 3.9k
Marina Pretolani France 37 2.7k 1.9× 318 0.3× 2.2k 2.4× 505 0.7× 1.2k 1.7× 109 5.4k
Carol Bickel United States 24 1.5k 1.1× 350 0.3× 1.5k 1.6× 273 0.4× 382 0.6× 41 3.0k
Hirokazu Okudaira Japan 37 1.1k 0.8× 376 0.3× 1.3k 1.4× 267 0.4× 782 1.2× 160 3.8k
Lothar Hültner Germany 33 1.0k 0.7× 338 0.3× 3.0k 3.2× 303 0.4× 874 1.3× 69 4.7k
Günter Menz Switzerland 33 2.8k 1.9× 387 0.3× 1.4k 1.5× 424 0.6× 407 0.6× 54 4.2k
Oliver Cromwell Germany 40 4.0k 2.8× 622 0.5× 1.3k 1.3× 423 0.6× 447 0.7× 129 6.3k

Countries citing papers authored by D A Loegering

Since Specialization
Citations

This map shows the geographic impact of D A Loegering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D A Loegering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D A Loegering more than expected).

Fields of papers citing papers by D A Loegering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D A Loegering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D A Loegering. The network helps show where D A Loegering may publish in the future.

Co-authorship network of co-authors of D A Loegering

This figure shows the co-authorship network connecting the top 25 collaborators of D A Loegering. A scholar is included among the top collaborators of D A Loegering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D A Loegering. D A Loegering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Husheng, John S. McDonald, Seongseok Yun, et al.. (2013). Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells. Haematologica. 99(1). 60–69. 25 indexed citations
2.
Lee, Sun Hee, X. Wei Meng, Karen S. Flatten, D A Loegering, & Scott H. Kaufmann. (2012). Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death and Differentiation. 20(1). 64–76. 168 indexed citations
3.
Kaufmann, Scott H., Judith E. Karp, W. Michael Hogan, et al.. (2011). Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia. Haematologica. 96(11). 1619–1626. 30 indexed citations
5.
Plager, Douglas A., et al.. (2000). Eosinophil Proteins. Respiratory Medicine. 94(10). 1011–1012. 1 indexed citations
6.
McGrogan, Michael, D A Loegering, James L. Checkel, et al.. (1995). Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein. The Journal of Immunology. 155(3). 1472–1480. 25 indexed citations
7.
Sorrentino, Salvatore, Dohn G. Glitz, K J Hamann, et al.. (1992). Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity.. Journal of Biological Chemistry. 267(21). 14859–14865. 119 indexed citations
8.
Gundel, Robert H., Gerald J. Gleich, James L. Checkel, et al.. (1991). Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP.. Journal of Clinical Investigation. 88(3). 798–805. 66 indexed citations
9.
Belongia, Edward A., Craig W. Hedberg, Gerald J. Gleich, et al.. (1990). An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use. New England Journal of Medicine. 323(6). 357–365. 244 indexed citations
10.
Ayars, Garrison H., L.C. Altman, Jan M. Agosti, et al.. (1989). Injurious Effect of the Eosinophil Peroxide-Hydrogen Peroxide-Halide System and Major Basic Protein on Human Nasal Epithelium In Vitro. American Review of Respiratory Disease. 140(1). 125–131. 86 indexed citations
11.
Loegering, D A, et al.. (1989). Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.. The Journal of Immunology. 143(3). 952–955. 108 indexed citations
12.
Loegering, D A, et al.. (1989). Blood eosinophils and eosinophil-derived proteins in allergic asthma. Journal of Allergy and Clinical Immunology. 84(6). 931–936. 127 indexed citations
13.
Gleich, Gerald J., D A Loegering, & Cheryl R. Adolphson. (1985). Eosinophils and Bronchial Inflammation. CHEST Journal. 87(1). 10S–13S. 30 indexed citations
14.
Ackerman, S.J., D A Loegering, Per Venge, et al.. (1983). Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.. The Journal of Immunology. 131(6). 2977–2982. 174 indexed citations
15.
Gleich, Gerald J., D A Loegering, Evangelo Frigas, & Warren V. Filley. (1983). The eosinophil granule major basic protein: biological activities and relationship to bronchial asthma.. PubMed. 18. 277–83. 5 indexed citations
16.
Loegering, D A, et al.. (1981). Recovery of eosinophils from the peritoneal cavity of the guinea pig. Journal of Immunological Methods. 41(1). 125–134. 9 indexed citations
17.
Wassom, Donald L., D A Loegering, Graham O. Solley, et al.. (1981). Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia.. Journal of Clinical Investigation. 67(3). 651–661. 190 indexed citations
18.
Frigas, Evangelo, D A Loegering, & Gerald J. Gleich. (1980). Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.. PubMed. 42(1). 35–43. 368 indexed citations
19.
Gleich, Gerald J., et al.. (1979). The effect of ablation of eosinophils on immediate-type hypersensitivity reactions.. PubMed. 38(2). 343–53. 16 indexed citations
20.
Lewis, David M., D A Loegering, & G J Gleich. (1976). Isolation and Partial Characterization of a Major Basic Protein from Rat Eosinophil Granules. Experimental Biology and Medicine. 152(4). 512–515. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026